Thalidomide-O-amido-PEG2-amine TFA salt CAS:1957235-75-4 is a chemical compound that contains several functional groups, including a thalidomide group, an amido group, a polyethylene glycol (PEG) spacer, an amine group, and a trifluoroacetic acid (TFA) group.
Thalidomide is a type of immunomodulatory drug that has been shown to be effective in treating certain types of cancer and inflammatory diseases. The amido group in Thalidomide-O-amido-PEG2-amine TFA salt is important for the stability and solubility of the compound in solution. The PEG spacer is used to improve the solubility and stability of the drug in solution, allowing it to be more easily administered to patients. The amine group can be used to react with other compounds, such as proteins or peptides, to create drug conjugates or targeted drug delivery systems. The trifluoroacetic acid group is important for the solubility and stability of the compound in solution, allowing it to be used in various biological applications.
Thalidomide-O-amido-PEG2-amine TFA salt has shown promise in the treatment of certain types of cancer and inflammatory diseases. By targeting specific immune cells and modulating their activity, this drug has the potential to improve outcomes for patients and extend their lives. Additionally, the amine group in this compound can be used to create drug conjugates or targeted drug delivery systems, allowing for more precise and effective treatment of certain types of diseases.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
